Fenofibrate alleviates insulin resistance by reducing tissue inflammation in obese ovariectomized mice

Abstract Background Fenofibrate is a hypolipidemic peroxisome proliferator-activated receptor α (PPARα) agonist used clinically to reduce hypercholesterolemia and hypertriglyceridemia. Objective We investigated the effects of fenofibrate on insulin resistance and tissue inflammation in a high-fat di...

Full description

Bibliographic Details
Published in:Nutrition & Diabetes
Main Authors: Jungu Lee, Suyeon Jeon, Mijeong Lee, Michung Yoon
Format: Article
Language:English
Published: Nature Publishing Group 2023-11-01
Online Access:https://doi.org/10.1038/s41387-023-00249-z

Similar Items